Product Information
ICOSAPENT ETHYL 0.5 GM CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3342 per EA under NDC 31722029824. Its NADAC has been published 126 times since May 8, 2024.
FDA first approved this application on Dec 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 g/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722029824
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ICOSAPENT ETHYLApproval Type
Generic (ANDA)
FDA Application
ANDA216811FDA Approved
12/7/2023
TE Code
AB
On Market Since
2/16/2024
Price Statistics
The NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has been published 126 times since May 8, 2024, and over the history we have for it it has declined 59.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3342 per EA |
|---|---|
| All-time high | $0.8322 (Nov 13, 2024) |
| All-time low | $0.3208 (Feb 18, 2026) |
| 52-week high | $0.5623 |
| 52-week low | $0.3208 |
| Median price | $0.5610 |
| Average price | $0.5374 |
| Largest weekly change | -24.1% (Nov 20, 2024) |
| Weeks tracked | 126 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Icosapent ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ICOSAPENT ETHYL 0.5 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 0.5 GM CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.3342 per EA (NDC 31722029824), effective Sep 30, 2026.
How has the price of ICOSAPENT ETHYL 0.5 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has declined 59.3%. It has been tracked across 126 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 0.5 GM CAPSULE?
Since May 8, 2024, the NADAC for ICOSAPENT ETHYL 0.5 GM CAPSULE has ranged from a low of $0.3208 (Feb 18, 2026) to a high of $0.8322 (Nov 13, 2024), with a median of $0.5610 per EA.
Are there cheaper alternatives to ICOSAPENT ETHYL 0.5 GM CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ICOSAPENT ETHYL 0.5 GM CAPSULE, is $0.3316 per EA — about 1% below ICOSAPENT ETHYL 0.5 GM CAPSULE.
Who manufactures ICOSAPENT ETHYL 0.5 GM CAPSULE?
ICOSAPENT ETHYL 0.5 GM CAPSULE (NDC 31722029824) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.